Financials
- Market Capitalization 798.53 M
- Employee 113
- Founded 2009
- CEO N/A
- Website www.aurabiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00226DGM5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2608 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.91 USD | -4.18% | -8.64% | +51.83% | +31.95% | 823.69 M USD | ||
| 2611 | NVCT Nuvectis Pharma, Inc. - Common Stock | 25.19 USD | +0.76% | +6.78% | +26.27% | +273.74% | 820.73 M USD | ||
| 2653 | STTK Shattuck Labs, Inc. - Common Stock | 7.65 USD | -3.16% | +4.08% | +11.68% | +665.00% | 767.78 M USD | ||
| 2656 | MNPR Monopar Therapeutics Inc. - Common Stock | 113.94 USD | +0.19% | +1.75% | +3.13% | +108.60% | 764.78 M USD |
Frequently asked questions about Aura Biosciences, Inc. Common Stock
What is the Aura Biosciences, Inc. Common Stock stock price today?
The current price of Aura Biosciences, Inc. Common Stock (AURA) is 7.70. Over the past 24 hours, the stock has changed by -0.39%. Follow the AURA chart for real-time price dynamics.
What is the stock ticker of Aura Biosciences, Inc. Common Stock?
Aura Biosciences, Inc. Common Stock trades under the ticker AURA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aura Biosciences, Inc. Common Stock stock going up?
AURA has changed by -0.90% over the last week, +9.53% over the last month, and +18.83% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Aura Biosciences, Inc. Common Stock?
Aura Biosciences, Inc. Common Stock currently has a market capitalization of 798.53 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Aura Biosciences, Inc. Common Stock earnings last quarter?
Last quarter, Aura Biosciences, Inc. Common Stock reported earnings of -0.48 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Aura Biosciences, Inc. Common Stock revenue for the last quarter?
Aura Biosciences, Inc. Common Stock reported quarterly revenue of 2.31 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Aura Biosciences, Inc. Common Stock net income for the last quarter?
Aura Biosciences, Inc. Common Stock reported net income of -45.64 M for the last quarter. The previous quarter showed -33.69 M, which means net income changed by -35.48%.
How many employees does Aura Biosciences, Inc. Common Stock have?
As of the latest available data, Aura Biosciences, Inc. Common Stock has 113 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aura Biosciences, Inc. Common Stock EBITDA?
Aura Biosciences, Inc. Common Stock EBITDA is -62.78 M, and its EBITDA margin is -2 721.37%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aura Biosciences, Inc. Common Stock stock?
You can buy Aura Biosciences, Inc. Common Stock (AURA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aura Biosciences, Inc. Common Stock stock?
Investing in Aura Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AURA chart and related analysis on metatrader.com as part of your research.